DICE Therapeutics
profile enables commercially viable dosing | DICE Therapeutics
Company
Deck Type
Deck date
March 2023
Slide
29 of 59
Similar slides by DICE Therapeutics
See diffirences between slides (animation)
Results
October 2022
| DICE Therapeutics
Results
October 2022
| DICE Therapeutics
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
October 2023
a half life of days in a format is expected to offer a superior product profile for patients | Aeglea BioTherapeutics
BioAtla
Investor Presentation
August 2023
concentration time profiles from different dosing regimens | BioAtla
BioAtla
Investor Presentation
May 2023
concentration time profiles from different dosing regimens | BioAtla
Other recent decks by DICE Therapeutics
See all presentations (4 decks)
Results
March 2023
Investor Presentation
March 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io